课题基金 / 基金详情

Examining the mechanisms for the lipolytic and antilipolytic effects of glucocorticoids in adipose tissue

Examining the mechanisms for the lipolytic and antilipolytic effects of glucocorticoids in adipose tissue
检查糖皮质激素在脂肪组织中的脂肪分解和抗脂肪分解作用的机制
批准号:
261306-2013
负责人:
Riddell, Michael
金额:
$2.4万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-01-01 至 2016-12-31

项目摘要

项目成果

Riddell, Michael的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Glucocorticoids (GCs) are naturally produced steroid hormones released by the activation of the hypothalamo-pituitary-adrenal (HPA) axis in a circadian rhythm and during times of stress (such as with exercise or starvation). GCs such as cortisol (humans) or corticosterone (rodents) have long been thought to be critical in helping to mobilize energy substrates for the organism when energy demands may be high and perhaps when food is relatively scarce (i.e. during fasting or during prolonged exercise). It is without controversy that GCs increase blood glucose levels by increasing hepatic glucose production and by limiting glucose disposal into skeletal muscle. Most texts, journals and websites also state that GCs help mobilize free fatty acids (FFAs) from adipocytes to help provide fuel for energy metabolism during exercise and a stress response by increasing adipose tissue lipase expression and/or activity. However, we and others have recently begun to discover that GCs, in fact, rapidly lower lipolysis rates in a dose-dependent fashion in fat cells and reduce FFA mobilization, at least in the short term. The purpose of this program renewal is to determine the physiological relevance of increases in GCs during times of stress (i.e. exercise, fasting, neurogenic stress) and the underlying mechanisms by which GCs have opposing roles in adipose tissue mobilization. We hypothesize that while GCs may change the "machinery" for lipolysis by changing gene transcription of key rate limiting lipases, they are actually antilipolytic via rapid non-genomic actions. The experiments that are outlined in this proposal will provide novel and important information about how GCs alter adipose tissue metabolism during a stress response. This research continues to provide an outstanding environment for trainees in the field of physiology and metabolism who are interested in Natural Sciences.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of somatostatin signalling on pancreatic islet function and energy homeostasis
  • 批准号:
    RGPIN-2018-05933
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.91万
  • 财政年份:
    2022
  • 负责人:
    Riddell, Michael
  • 依托单位:
Role of somatostatin signalling on pancreatic islet function and energy homeostasis
  • 批准号:
    RGPIN-2018-05933
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.91万
  • 财政年份:
    2021
  • 负责人:
    Riddell, Michael
  • 依托单位:
Role of somatostatin signalling on pancreatic islet function and energy homeostasis
  • 批准号:
    RGPIN-2018-05933
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.91万
  • 财政年份:
    2020
  • 负责人:
    Riddell, Michael
  • 依托单位:
Role of somatostatin signalling on pancreatic islet function and energy homeostasis
  • 批准号:
    RGPIN-2018-05933
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.91万
  • 财政年份:
    2019
  • 负责人:
    Riddell, Michael
  • 依托单位:
国内基金
海外基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI Z
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
  • 批准号:
    82371255
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    曹立
  • 依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
  • 批准号:
    82370979
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张善勇
  • 依托单位: